Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02965040
What this trial is testing

Roxadustat in Subjects With Different Degrees of Renal Function

Who this might be right for
Normal Renal FunctionImpaired Renal Function
Astellas Pharma Europe B.V. 34
Large-scale testing (Phase 3)Study completedNCT01501513
What this trial is testing

A Safety Study of 3 Different Bowel Cleansing Preparations

Who this might be right for
ColonoscopyBowel PreparationEndoscopy
Braintree Laboratories 541
Post-approval studies (Phase 4)Ended earlyNCT00793182
What this trial is testing

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

Who this might be right for
Renal Impairment
Guerbet 6
Early research (Phase 1)Study completedNCT04646889
What this trial is testing

Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Arthrosi Therapeutics 46
Early research (Phase 1)Study completedNCT04365218
What this trial is testing

Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
AstraZeneca 12
Early research (Phase 1)Study completedNCT01948986
What this trial is testing

Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)

Who this might be right for
Renal ImpairmentType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 36
Large-scale testing (Phase 3)Study completedNCT05075408
What this trial is testing

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

Who this might be right for
Chronic Kidney Disease Associated Moderate to Severe Pruritus
Galderma R&D 258
Large-scale testing (Phase 3)Study completedNCT02968368
What this trial is testing

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

Who this might be right for
Renal Insufficiency, ChronicIron-Deficiency Anemia
Shield Therapeutics 167
Early research (Phase 1)Study completedNCT01233882
What this trial is testing

Bosutinib In Subjects With Renal Impairment

Who this might be right for
Renal Disease, End-StageRenal Insufficiency, ChronicRenal Insufficiency, Acute
Pfizer 34
Large-scale testing (Phase 3)Looking for participantsNCT03633708
What this trial is testing

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 56
Early research (Phase 1)Study completedNCT06671444
What this trial is testing

Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment

Who this might be right for
InsomniaRenal Impairment
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 16
Early research (Phase 1)Study completedNCT04565171
What this trial is testing

Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD

Who this might be right for
Renal Impairment
Sunshine Lake Pharma Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT00709865
What this trial is testing

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Who this might be right for
Renal InsufficiencyCongestive Heart Failure
Biogen 420
Early research (Phase 1)Study completedNCT03605277
What this trial is testing

Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT00828438
What this trial is testing

Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 40
Not applicableLooking for participantsNCT06907147
What this trial is testing

SPYRAL GEMINI Pilot Study

Who this might be right for
HypertensionVascular DiseasesCardiovascular Diseases+2 more
Medtronic Vascular 175
Early research (Phase 1)Study completedNCT06132204
What this trial is testing

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 16
Early research (Phase 1)Study completedNCT04178577
What this trial is testing

Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function

Who this might be right for
Renal Impairment
Spero Therapeutics 39
Early research (Phase 1)Study completedNCT01934166
What this trial is testing

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
H. Lundbeck A/S 32
Testing effectiveness (Phase 2)UnknownNCT03015623
What this trial is testing

Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy

Who this might be right for
Acute Kidney Injury
Sentien Biotechnologies, Inc. 24
Next Page